GRTS Gritstone bio, Inc. Net earnings per share growth this year

GRTS (gritstonebio.com) - company brandmark

The annual percentage growth of net income per share reflects the asset's value dynamics, where the current level is 29.70, correlating with the control of water consumption and filtration within laboratories. The business foundation of Gritstone bio, Inc. (GRTS) relies on bioethics and the minimization of chemical waste during mRNA vaccine synthesis, as well as basic recycling and research safety oversight.

Gritstone bio (GRTS): Net earnings per share growth this year from 07/04/2022 to 11/02/2024

Analytical breakdowns and data insights for company gritstonebio.com (GRTS)

- current quotes and average value forecast:
Summary company analysis:GRTS (Gritstone bio)
Brand item of Gritstone bio, Inc.

The market assesses Gritstone bio, Inc. (GRTS) as a high-risk asset due to a critical reduction in vaccine development and financial instability. The annual EPS growth rate measures the percentage change in net income per share, reflecting the business's ability to generate income relative to the previous year. In a bankruptcy context, this chart serves as a survival indicator, where any profit growth only partially offsets the risks of cash flow gaps.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|minktherapeutics.com - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics, Inc.|Immix (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings - Earnings per share increase in current year|Earnings per share growth in current year Cue Biopharma|Earnings growth in current year pdsbiotech.com|Earnings per share growth in current year sonnetbio.com (SONN)|MAIA: Earnings per share trend in current year|Liminatus Pharma Inc. - Net earnings per share growth this year|LAVA Therapeutics N.V. (LVTX) - Earnings per share growth rate in current year|NXTC - Earnings per share growth in current year|LPTX: Earnings per share growth in current year|Intensity Therapeutics (INTS) - Earnings per share growth in current year|Earnings per share growth rate in current year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year